FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Guilty Plea in Dietary Supplement Case

Chinese citizen Gao Mei Fang pleads guilty to smuggling and mail fraud charges arising from a scheme to sell mislabeled dietary supplements.

Medical Devices

Jury Awards Plaintiff $3.6 Million in Bard Device Case

An Arizona federal jury awards a plaintiff $3.6 million in a bellwether case involving C.R. Bards inferior vena cava filter.

Human Drugs

Fast Track for Triple Combination for Cystic Fibrosis.

FDA grants Proteostasis Therapeutics a fast track designation for its triple combination product for treating cystic fibrosis.

Federal Register

Aninal Drug Regulations Amended to Reflect Approvals, Etc.

Federal Register Final Rule: FDA amends the animal drug regulations to reflect recent application-related actions for NADAs and ANADAs.

Human Drugs

Pfizer NDA for Lung Cancer Drug Given Priority Review

FDA accepts for priority review a Pfizer NDA for dacomitinib, a pan-human epidermal growth factor receptor tyrosine kinase inhibitor, for first-line t...

Medical Devices

Aeskuslides nDNA (Crithidia Luciliae) Assay Cleared

FDA clears an Aesku Group 510(k) for its Aeskuslides nDNA (Crithidia luciliae) assay and its use on the companys new Helios Automated IFA System.

Federal Register

Editorial, Typographical Corrections in Device Regs

Federal Register Final Rule; technical amendment: FDA amends certain medical device regulations to correct editorial issues, such as typographical err...

Human Drugs

Endo Agrees to Temporary Litigation Stay Extension

Endo agrees to extend for 180 days a stay in its suit against FDA over agency policy in compounding using bulk drug substances.

Medical Devices

Glucose Meter Benefits Outweigh Risks Panel Says

FDA panel members are divided on CLIA waivers for using glucose meters to measure blood glucose in capillary blood in patients receiving intensive med...

Human Drugs

FDA Celltrion Yeonsu-go Inspection Report Out

FDA releases the establishment inspection report from its 2017 inspection at the Celltrion Yeonsgu-go Plant 1 in Inchon, Korea.